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Eicosanoids mediate insect nodulation responses to
bacterial infections
(cyclooxygenase/lipoxygenase/phospholipase A2/Manduca sexta/Serratia marcescens)
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ABSTRACT We propose that nodule formation is medi-
ated by eicosanoids in insects. Nodulation is the temporally and
quantitatively predominant cellular defense response to bac-
terial infection in insects and other invertebrates. Inhibition of
eicosanoid biosynthesis in larvae of the tobacco hornworn
Manduca sexta immediately prior to intrahemocoelic infections
with the bacterium Serratia marcescens strongly reduced the
nodulation response. Inhibition of eicosanoid biosynthesis also
reduced formation of cellular aggregates at 1 hr postinfection,
which indicates that eicosanoids mediate early stages of nod-
ulation. Separate treatments with specific inhibitors of phos-
pholipase A2, cyclooxygenase, and lipoxygenase reduced nod-
ulation, which supports the view that nodule formation is a
complex process involving prostaglandins and lipoxygenase
products. The inhibitory effects of the phospholipase A2 inhib-
itor dexamethasone on nodulation were apparent by 1 hr after
infection, and the effects increased, relative to controls, over 24
hr. The dexamethasone effects were expressed in a dose-
dependent manner, and they were reversed by treating infected
insects with eicosanoid-precursor polyunsaturated fatty acids.
Treatments with the saturated fatty acid 16:0, which is not an
eicosanoid precursor, did not reverse the dexamethasone ef-
fects on nodulation. These findings strongly support the iden-
tification of nodulation as a specific insect cellular defense
mechanism that is mediated by eicosanoids.
Insects elaborate two broad categories of defense responses
to bacterial infections, humoral and hemocytic (1-3). Hu-
moral responses involve induced synthesis of antibacterial
proteins such as cecropins (4 kDa), attacins (12-23 kDa),
diptericins (8 kDa), and defensins (4 kDa) (3). The detergent
properties ofthese antibacterial proteins disrupt bacterial cell
membranes. Insects also synthesize lysozymes, enzymes
that directly attack bacteria by hydrolyzing their peptidogly-
can cell walls (4, 5). Hemocytic responses feature direct
interactions between circulating hemocytes and bacteria.
Specific cellular defense mechanisms include phagocytosis,
nodulation, and encapsulation (1, 2).
We recently suggested that insect cellular immune re-
sponses to bacterial infections are mediated by eicosanoids
(6). We observed the effects of pharmaceutical inhibitors of
eicosanoid biosynthesis on the ability of the tobacco horn-
worm Manduca sexta to clear artificial infections from its
circulation. Inhibition of total eicosanoid biosynthesis, with
injections of the phospholipase A2 (PLA2) inhibitor dexa-
methasone, severely reduced the hornworm's ability to clear
injected bacteria from its hemolymph and increased larval
mortality due to the bacterial infections. Inhibition of either
of two specific eicosanoid biosynthesis pathways, cyclooxy-
genase and lipoxygenase, also reduced clearance of bacteria
but to a lesser extent compared to the effects of completely
inhibiting eicosanoid biosynthesis. On the basis of these
findings, we proposed that eicosanoid products of the cyclo-
oxygenase and lipoxygenase pathways are involved in insect
immune responses to bacterial infections. Because most of
our experiments were done during the first hour postinfection
(PI), long before the appearance of antibacterial proteins in
insect hemolymph, we suggested that eicosanoids mediate
one or more hemocytic defense responses (6).
This suggestion opens a crucial question: which of the
hemocytic defense mechanisms are mediated by eicosa-
noids? Because nodulation (see Fig. 1) is the quantitative
major defense response (7), we hypothesized that nodulation
is one of the cellular defense mechanisms that is mediated by
eicosanoids in insects. In this paper we describe outcomes of
experiments designed to test our hypothesis.
MATERIALS AND METHODS
Organisms. Fifth-instar M. sexta larvae weighing 4-6 g
were used in all experiments. Larvae were reared from eggs
provided in weekly shipments by J. Buchner (Department of
Agriculture/Agricultural Research Service Biosciences Re-
search Laboratory, Fargo, ND). The larvae were reared on
an artificial diet under the semisterile conditions developed
by Dunn and his colleagues (7, 8).
Cultures of a nonpigmented strain of Serratia marcescens
and nutrient broth (Difco) were purchased from Carolina
Biological Supply. Bacteria were grown in 50 ml of nutrient
broth in an environmental shaker at 37°C and 100 rpm.
Bacteria were used in midlogarithmic or stationary phase at
a dose of 2.5-7.0 x 107 colony-forming units per ml (6).
Injections and Assays for Aggregate Formation and Nodu-
lation. Test larvae were injected with either the PLA2 inhib-
itor dexamethasone [(11X,16a)-9-fluoro-11,17,21-trihydroxy-
16-methylpregna-1,4-diene-3,20-dione]; the arachidonic acid
analog 5,8,11,14-eicosatetraynoic acid (ETYA); one of the
cyclooxygenase inhibitors indomethacin [1-(p-chloroben-
zoyl)-5-methoxy-2-methyl-3-indolyl-acetic acid], naproxin
[d-2-(6-methoxy-2-naphthyl)propionic acid], ibuprofen [2-(4-
isobutylphenyl)propionic acid], or piroxicam [3,4-dihydro-2-
methyl-4-oxo-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxa-
mide 1,1-dioxide]; the dual cyclooxygenase and lipoxygenase
inhibitor phenidone [1-phenyl-3-pyrazolidinone]; or the 5-
and 12-lipoxygenase inhibitor esculetin [6,7-dihydroxy-
coumarin] (all inhibitors from Biomol, Plymouth Meeting,
PA). In some experiments, larvae were also injected with
arachidonic acid (5,8,11,14-eicosatetraenoic acid), eicosap-
entaenoic acid (5,8,11,14,17-eicosapentaenoic acid), or palm-
itic acid (hexadecanoic acid) (Sigma). Control larvae were
injected with nutrient broth or 95% ethanol. All injections of
pharmaceuticals were in a standard volume of 10 ,ul. The
Abbreviations: LSD, least significant difference; PI, postinfection;
PLA2, phospholipase A2; PUFA, polyunsaturated fatty acid; ETYA,
eicosatetraynoic acid.
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pharmaceutical products were injected at doses of 26 ug per
larva, except in the dose-response experiments, and the fatty
acids were injected at doses of 50 pg per larva.
Larvae were surface sterilized by swabbing their surfaces
with 95% ethanol. Bacteria (2.5-7.0 x 107 colony-forming
units per ml) were injected in 100-,l aliquots, using a 26-
gauge 0.5-inch needle attached to a 1-ml syringe (Becton
Dickinson). Drugs and control substances were injected in
10-.ul aliquots into the opposite side of the larvae using a
Hamilton 701 syringe (Hamilton) (6).
Hemocyte aggregation (Fig. 1A) was assessed at 1 hr PI.
Larvae were anesthetized by chilling on ice and then he-
molymph was collected by periocardial puncture, using Tef-
lon-lined needles as described by Horohov and Dunn (7). One
drop of freely flowing hemolymph was applied to a Bright-
Line hemacytometer (AO Instrument, Buffalo, NY). The
number of cellular aggregates in each sample was estimated
by direct observation of every field under phase-contrast
optics. Total hemocyte count in the same samples was
estimated by counting every field on the hemacytometer (7).
Nodulation (Fig. 1B) was assessed at selected times PI.
Larvae were anesthetized by chilling on ice, and then the
FIG. 1. Photomicrographs of early and late phases of nodulation
in response to bacterial infections. (A) Photomicrograph ofhemocyte
aggregation in response to bacterial infection. The cells and aggre-
gate are shown against the background of the hemacytometer used
in routine assessments at 1 hr PI using a Nikon Optiphot microscope
equipped with phase-contrast optics and a Nikon FX-35A camera.
Hemocyte aggregation is an early step in nodule formation. (B)
Photomicrograph of melanized nodules in response to bacterial
infection. The solid arrow points to one of several visible nodules,
seen in situ against the background of larval fat body. This photo-
graph was taken during routine assessment of nodulation at 6 hr PI
using an Olympus SZ series stereomicroscope equipped with a SC 35
camera. (A, x260; B, x40; photographs by J.S.M.)
hemocoels were exposed. Melanized, dark nodules were
counted under a stereomicroscope. After the initial counting,
the alimentary canal was excised. Nodules in the previously
unexposed areas and remaining internal tissues were then
counted. The sizes ofselected nodules were determined using
an optical micrometer.
Background Control Experiments. Because the insects
used in these experiments were reared under semisterile
conditions, it was expected that the insects would have very
few nodules before the treatments. To determine background
nodulation, a total of 20 larvae were taken from culture, at
various times in this project, and anesthetized on ice for 10
min; nodulation was assessed as just described. To assess the
influence of injection wounds on nodule formation, nine
larvae were treated by intrahemocoelic injection of a stan-
dard volume of ethanol. Nodulation was assessed 6 hr later.
To assess the effect of dexamethasone on nodulation in
uninfected larvae, 26 pg ofdexamethasone in 10 ,ul ofethanol
was injected into 15 larvae. Nodulation was assessed 6 hr
later. To control for the possibility that nutrient broth could
stimulate nodulation, 14 larvae were similarly treated by
intrahemocoelic injection of a standard volume (100 ul) of
nutrient broth. Nodulation was assessed 6 hr later.
Time Course of Nodulation: Influence of Dexamethasone.
Individuals in two groups of larvae were treated with 10 MI of
ethanol or with 26 pg of dexamethasone in 10 Ad of ethanol
and then infected with S. marcescens as described. At 1, 3,
4, 6, and 24 hr PI, subgroups of control and experimental
larvae were anesthetized, and nodulation was assessed.
Dose-Response Relationship for Dexamethasone. Individu-
als in seven groups of larvae were treated with 10 j4 of
ethanol or with 2.6 x 10-4, 2.6 x 10-3, 2.6 x 10-2, 2.6 x 10-1,
2.6, or 26.0 ,ug ofdexamethasone in 10 Au of ethanol and then
were infected with S. marcescens as described. At 6 hrPI, the
larvae were anesthetized, and nodulation was assessed.
Fatty Acid Rescue Experiments. Individuals in two groups
of larvae were injected with either 10 Ad of ethanol or 26 pg
of dexamethasone in 10 A1 of ethanol and then infected with
S. marcescens as described. Immediately after infection, the
dexamethasone-treated larvae were divided into four sub-
groups. Individuals in each of three subgroups were treated
with 50-pg injections of either arachidonic acid, eicosapen-
taenoic acid, or palmitic acid in 5 ,ul of ethanol. Individuals
in the fourth subgroup were similarly treated with 5 A1 of
ethanol to control for the effects of the extra injection on
nodulation. At 6 hr PI, the larvae were anesthetized, and
nodulation was assessed.
Influence of Other Elcosanoid Biosynthesis Inhibitors on
N-odulation. Individuals in groups of test larvae were injected
with either one of the cyclooxygenase inhibitors (indometh-
acin, naproxin, ibuprofen, or piroxicam), the dual cyclooxy-
genase and lipoxygenase inhibitor phenidone, the lipoxyge-
nase inhibitor esculetin, or the arachidonic acid analog
ETYA, all in 10 p1 of ethanol. Control larvae were injected
with 10 Al of ethanol. Three to 10 min after injection of the
inhibitors or ethanol, the larvae were infected with S. mar-
cescens as described. At 6 hr PI, the larvae were anesthe-
tized, and nodulation was assessed.
Statistical Analyses. Significant treatment effects were con-
firmed for hemocyte aggregation by Student's t test with P c
0.10. Significant treatment effects were confirmed for all
nodulation experiments by analysis of variance with P-c
0.01. Where appropriate, significant differences among treat-
ment means were determined by protected least significant
difference (LSD).
RESULTS
Hemocyte Aggregation and Total Hemocyte Count. Table 1
displays the influence of dexamethasone on the number of
Physiology: MiRer et al.
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Table 1. Number of hemocyte aggregates and total hemocyte
counts from tobacco hornworm larvae that were treated with
dexamethasone or with vehicle
No. of hemocyte No. of
aggregates Total hemocyte individual
Treatment x 10-6 count x 10-6 larvae
Vehicle only 8.37 ± 1.7 6.72 ± 8.2 7
Dexamethasone 1.95 ± 1.1* 10.62 ± 1.52* 4
Insects were treated with dexamethasone or with vehicle and then
injected with bacteria. Numbers of hemocyte aggregates and total
hemocyte counts were assessed at 1 hr PI; the values represent
numbers of aggregates (mean ± SE) per ml of hemolymph.
*Significantly different from controls (P < 0.10).
hemocyte aggregations in hemolymph circulation at 1 hr PI.
Compared to control larvae, about 4-fold fewer hemocyte
aggregates were recovered from dexamethasone-treated lar-
vae. The decreased recovery of hemocyte aggregates was
reflected in significantly increased total hemocyte counts.
The influence of dexamethasone on the number of hemocyte
aggregates and on total hemocyte counts indicates that dex-
amethasone impacted visible nodule formation through its
effects on hemocyte aggregation. In the following para-
graphs, we describe the influence of probing eicosanoid
biosynthesis on formation of visible nodules.
Background Control Experiments. The results of the con-
trol experiments are displayed in Table 2. No nodules were
observed in larvae that were taken directly from the semi-
sterile rearing conditions. To examine the effects of injection
on nodule formation, 10-,ul doses of ethanol, the standard
carrier vehicle for all pharmaceuticals, were injected into
larvae. No nodules were observed in eight of nine larvae, and
4 nodules were observed in one larva. Dexamethasone treat-
ments caused about 1 nodule per larva. Treatments with
nutrient broth resulted in about 6 nodules per larva. Injec-
tions of standard dosages of S. marcescens resulted in about
121 nodules per larva. Throughout the course of this project,
the sizes of selected nodules were estimated. A total of 762
nodules were sized, of which 98% were about 0.1 mm in
diameter, 1% were 0.2 mm in diameter, and the remainder
were 0.3-0.5 mm in diameter.
Time Course of Nodulation. Fig. 2 displays the time course
of visible nodulation in two groups of larvae. Dexametha-
sone-treated larvae formed about 4 nodules at 1 hr PI, which
increased to 30 at 6 hr PI and 42 nodules per larva at 24 hr PI.
The ethanol-treated control larvae produced significantly
more nodules at each time point, from 21 nodules at 1 hr PI
to 122 at 6 hr PI and 148 nodules per larva at 24 hr PI (LSD,
P < 0.01). Nodulation was not substantially increased by 24
hr PI, and in all subsequent experiments nodulation was
assessed at 6 hr PI.
Dose-Response Curve for Dexamethasone. The relationship
between dexamethasone dose and number of nodules is
shown in Fig. 3. Increased dexamethasone doses (0, 2.6 x
10-4, 2.6 x 10-3, 2.6 x 10-2, 2.6 x 10-1, 2.6, and 26.0 pg per
larva) were associated with decreased nodulation in response
to bacterial infections, from 134 to 30 nodules per larva. Mean
Table 2. Outcomes of background control experiments
Nodules per larva, No. of
Treatment mean ± 1 SEM larvae
None 0 20
Vehicle only 0.4 ± 0.4 9
Dexamethasone only 1.0 ± 0.6 15
Nutrient broth only 6.2 ± 0.5 14
Bacteria only 121.5 ± 13.9 18
Nodulation was assessed at 6 hr PI.
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FIG. 2. Time course of M. sexta nodulation in response to
intrahemocoelic infections with the pathogenic bacterium S. mar-
cescens. Test larvae were first injected with dexamethasone (dashed
line), and control larvae were first injected with ethanol (solid line).
Within 3-10 min, both groups of insects were then intrahemocoeli-
cally infected with -5 x 105 bacterial cells. At the indicated times
after infection, the insects were anesthetized on ice, and nodulation
was assessed. Each point indicates the mean number of nodules
found in each larva, and the error bars represent 1 SEM. The
numbers in parentheses indicate the number of larvae.
nodulation was significantly related to dexamethasone dose
(y = -3.04 x + 109, R2 = 0.716, F = 15.96).
Fatty Acid Rescue Experiments. As we have just seen,
dexamethasone treatments inhibited the ability of tobacco
homworm larvae to form nodules in response to bacterial
infections. On the basis of the model that dexamethasone
inhibits eicosanoid biosynthesis through its effects on PLA2,
we reasoned that injecting eicosanoid-precursor polyunsat-
urated fatty acids (PUFAs) into dexamethasone-treated, in-
fected larvae should reverse the effects of dexamethasone on
nodulation. To test this, larvae were treated in the following
sequence: after injection with dexamethasone, larvae were
infected with bacteria and then immediately treated with 50
pg of arachidonic acid, eicosapenatenoic acid, or palmitic
acid in 5 ,ul of ethanol. To control for the possibility that the
extra injection stimulated nodulation, some larvae were
injected with 5 ,ul of ethanol. At 6 hr PI, the larvae were
examined for nodulation. Fig. 4 shows that the arachidonic
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FIG. 3. Dose-response curve for the effects ofdexamethasone on
nodule formation. M. sexta larvae were first injected with the
indicated doses of dexamethasone and then intrahemocoelically
infected with -5 x 105 cells of the bacterium S. marcescens. After
6 hr of incubation, the insects were anesthetized on ice, and
nodulation was assessed. Each point indicates the mean number of
nodules found in each larva, and the error bars represent 1 SEM. The
numbers in parentheses indicate the number of larvae. The dashed
line represents y = -3.04x + 109.
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FIG. 4. Eicosanoid-precursor fatty acids reversed the dexameth-
asone effect on nodulation. M. sexta larvae were treated with ethanol
(EtOH) or dexamethasone (DEX) and then intrahemocoelically
infected with -5 x 105-cells of the insect pathogen S. marcescens.
Immediately after infection, test larvae were treated with 50 4sg of
either palmitic acid (DEX + PA), arachidonic acid (DEX + AA), or
eicosapentaenoic acid (DEX + EPA). Control larvae were treated
with ethanol (DEX + EtOH). At 6 hr PI, the larvae were anesthe-
tized, and nodulation was assessed. The height of histogram bars
represents the mean number of nodules found in each larva, and the
error bars represent 1 SEM. The number of larvae in each category
is indicated above the error bars. Histogram bars with the same fill
pattern are not significantly different from each other (LSD, P <
0.01).
acid and eicosapentaenoic acid treatments reversed the ef-
fects of dexamethasone on nodulation. Ethanol-injected con-
trol larvae produced about 121 nodules per larva, and dex-
amethasone-treated larvae produced about 43 nodules per
larva, as expected from earlier experiments. The arachidonic
acid-treated larvae produced about 140 nodules per larva, on
par with the control animals. Ethanol-treated, dexametha-
sone-treated larvae produced about 50 nodules, which indi-
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FIG. 5. Effect of treating M. sexta larvae with individual ei-
cosanoid biosynthesis inhibitors on nodule formation in response to
intrahemocoelic infections with the insect pathogen S. marcescens.
Test larvae were first injected with 26 jig of either dexamethasone
(DEX; PLA2 inhibitor), esculetin (ESC; lipoxygenase inhibitor),
indomethacin (INDO), naproxin (NAP), ibuprofen (IBU), or piroxi-
cam (PIRO; cyclooxygenase inhibitors), phenidone (PHEN; dual
cyclooxygenase/lipoxygenase inhibitor), or ETYA (arachidonate
analogue, inhibits all arachidonate metabolism). Control larvae were
first injected with ethanol (EtOH). Test and control larvae were then
intrahemocoelically infected with -5 x 105 cells of the insect
pathogen S. marcescens. At 6 hr PI, larvae were anesthetized, and
nodulation was assessed. The height of histogram bars represents the
mean number of nodules found in each larvae, and the error bars
represent 1 SEM. The number of larvae in each category is indicated
above the error bars. Histogram bars with the same fill pattern are
not significantly different from each other (LSD; P < 0.01).
cates that a second injection did not exert a significant effect
on nodulation. Another eicosanoid-precursor PUFA, eicos-
apentaenoic acid, similarly reversed the dexamethasone ef-
fects (Fig. 4). The rescue effects were specific to eicosanoid-
precursor PUFAs, because palmitic acid (16:0), which cannot
be desaturated to form C20 PUFAs, did not restore nodula-
tion to control levels (LSD, P < 0.01).
Influence of Other Eicosanoid Biosynthesis Inhibitors on
Nodulation. To dissect the possible roles of cyclooxygenase
and lipoxygenase pathways in nodulation, larvae were
treated with standard doses offour cyclooxygenase inhibitors
(indomethacin, naproxin, ibuprofen, or piroxicam), the dual
cyclooxygenase and lipoxygenase inhibitor phenidone, the 5-
and 12-lipoxygenase inhibitor esculetin, or the arachidonate
analog ETYA and then artificially infected with bacteria. Fig.
5 shows that compared to control larvae, all test larvae
exhibited significantly reduced nodulation in response to
bacterial infections (LSD, P < 0.01). There were no signif-
icant differences among the effects of individual inhibitors on
nodulation.
DISCUSSION
The data described here permit us to identify nodulation as
one ofthe specific cellular defense responses that is mediated
by eicosanoids in insects. This insight is supported by the
following points. First, the dexamethasone effect on nodu-
lation began within the first hour PI and increased relative to
control animals throughout the time course of the experi-
ments. Second, the dexamethasone effects on nodule forma-
tion were expressed in a dose-dependent manner. Third, the
influence of dexamethasone was reversed by treating the
larvae with free eicosanoid-precursor fatty acids. Finally,
inhibition of eicosanoid biosynthesis with specific inhibitors
of PLA2, cyclooxygenase, and lipoxygenase significantly
reduced nodulation in infected hornworms. Nodules are
easily visible in tobacco hornworms because they are darkly
melanized, and it is not immediately clear whether ei-
cosanoids mediate aggregation of hemocytes, which leads to
nodulation, or if eicosanoids mediate the melanization reac-
tions, which would make nodules easily visible. Because
significantly reduced numbers of circulating aggregates were
recovered from dexamethasone-treated larvae at 1 hr PI, we
postulate that eicosanoids mediate early steps in nodule
formation. This idea is also supported by the influence of
dexamethasone on total hemocyte counts in infected larvae.
In their work on tobacco homworm larvae, Geng and Dunn
(9) found that bacterial infections elicited decreased circu-
lating hemocyte numbers, presumably due to investing hemo-
cytes in nodule formation. In our experiments, ethanol-
treated larvae yielded larger numbers of cellular aggregates
and smaller total hemocyte counts, whereas dexamethasone-
treated larvae yielded fewer cellular aggregates and greater
total hemocyte counts. Again, while not ruling out the
possible influence of eicosanoids on melanization reactions,
we propose that eicosanoids mediate the nodulation response
to bacterial infections in insects. The significance of this
insight lies in a broad understanding of immunological de-
fenses in invertebrates: nodulation is a primary means of
responding to bacterial infections in arthropods and in other
phyla. To the extent that immune responses in tobacco
hornworms model invertebrate immunity, eicosanoid biosyn-
thesis is a fundamental and crucial step in the mediation of
cellular defense reactions.
Because the melanization responses to injection wounds
can produce the appearance of nodulation, we conducted
experiments designed to control for background nodulation
(Table 2). To minimize background nodulation, the tobacco
hornworms were reared in the semisterile culture conditions
developed by Dunn and colleagues (7, 8). No nodules were
Physiology: Miller et al.
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seen in insects taken directly from our culture. Injections of
the drug vehicle, of dexamethasone, and of sterile nutrient
broth uniformly resulted in negligible background nodulation
(Table 2). These data indicate that the nodulation we ob-
served was a specific response to bacterial infections and not
a reflection of the insects' background health.
The experimental treatments could result in widely varying
nodule sizes that might obscure accurate nodulation assess-
ments. We recorded the sizes of over 750 nodules, 98% of
which were about 0.1 mm in diameter. The uniform nodule
sizes suggest that our assessments accurately index the
nodulation response to bacterial infections.
The linear relationship between logarithmically increasing
dexamethasone doses and decreasing nodulation and also
reversing the dexamethasone effects on nodulation with
eicosanoid-precursor PUFAs (Figs. 3 and 4) powerfully argue
that eicosanoids mediate the insect nodulation response to
bacterial infections. The dexamethasone effects on ei-
cosanoid biosynthesis are thought to act at the level of PLA2,
which catalyzes hydrolysis ofPUFAs from cellular phospho-
lipids. If dexamethasone exerts its effects by inhibiting PLA2
in M. sexta, then subsequent treatments with eicosanoid-
precursor PUFAs should reverse the dexamethasone effects.
Fig. 4 shows that two eicosanoid-precursor PUFAs, arachi-
donic acid and eicosapentaenoic acid, restored nodulation in
dexamethasone-treated, infected hornworms. An apparent
restoration of nodulation could have resulted from nonspe-
cific effects, such as additional handling, the extra injection
required to administer the fatty acids after infecting the
larvae, or a pharmacological effect of the fatty acids. How-
ever, handling and injecting 5 ,ul of ethanol into dexametha-
sone-treated, infected larvae did not increase nodulation.
Similarly, injecting palmitic acid, which cannot lead to ei-
cosanoid biosynthesis, appeared to slightly increase nodula-
tion, but did not restore nodulation to the level seen in control
larvae or eicosanoid-precursor PUFA-treated larvae. These
experiments support the idea that eicosanoids mediate the
nodulation response to bacterial infections in insects.
Fig. 5 indicates that a wide range of eicosanoid biosynthe-
sis inhibitors effectively reduced nodulation in infected lar-
vae. The point to offer is that various eicosanoids, including
cyclooxygenase and lipoxygenase products, may be involved
in a number of specific cellular events in the complete
nodulation process. Inhibition of any one or more of the
eicosanoid-mediated steps may negatively impact the overall
nodule formation. If this is so, it would not be surprising that
inhibition of either of the major eicosanoid-biosynthetic
pathways would similarly inhibit nodulation.
A major difficulty with using pharmaceutical inhibitors to
probe the possible roles of eicosanoids in physiological
systems in invertebrates is the possibility of nonspecific or
nonphysiological effects (10). We have addressed this issue
by arguing from cases in which the inhibitors we used have
been shown to have similar pharmacological actions in in-
vertebrates and in mammals (6). Moreover, we recently
obtained biochemical evidence that very low levels of
naproxin and indomethacin (0.001 ,uM) strongly inhibited
cyclooxygenase activity in fatty body and hemocyte prepa-
rations (11-13). Use of inhibitors to probe these pathways
also rests upon the assumption that the inhibitory compounds
reach the target tissues in vivo. We also have learned that one
inhibitor, indomethacin, is rapidly accumulated from he-
molymph circulation by tobacco hornworm tissues, including
hemocytes and fat body (J.S.M. and D.W.S.-S., unpublished
results). Considerably more work on the pharmacology and
the quantitative influence ofputative eicosanoid biosynthesis
inhibitors on in vivo eicosanoid titers in insects is required
before these compounds can be completely accepted as
probes to assess the influence of eicosanoids in insect phys-
iology (10). In the meantime, drawing on the evidence just
cited, we propose that the compounds used in our experi-
ments express their effects through inhibition of eicosanoid
biosynthesis.
Cyclooxygenase and lipoxygenase products are crucial
mediators ofmany aspects ofmammalian physiology, includ-
ing cellular host defense actions. For example, cyclooxygen-
ase products have profound effects on macrophage locomo-
tion, cell shape changes, and phagocytosis (14); and lipoxy-
genase products mediate chemotaxis, chemokinesis, and
adherence responses of neutrophils (15). Coupled with the
background of mammalian studies, our findings with tobacco
hornworms allow us to propose that eicosanoids mediate
cellular defenses in vertebrates and invertebrates. This idea
is also supported by recent findings on blood cells from the
crab Carcinus maenas. These cells biosynthesize ei-
cosanoids, including cyclooxygenase and lipoxygenase prod-
ucts (16), which may similarly mediate defense responses.
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